002688 金河生物
已收盘 11-13 15:00:00
资讯
新帖
简况
股市必读：金河生物新发布《关于子公司获得新兽药注册证书的公告》
证券之星 · 11-12 03:56
股市必读：金河生物新发布《关于子公司获得新兽药注册证书的公告》
金河生物（002688）披露子公司获得新兽药注册证书公告，11月10日股价下跌0.43%
证券之星 · 11-10
金河生物（002688）披露子公司获得新兽药注册证书公告，11月10日股价下跌0.43%
金河生物(002688.SZ)：牛结节性皮肤病灭活疫苗(NMG株)获得新兽药注册证书
智通财经 · 11-10
金河生物(002688.SZ)：牛结节性皮肤病灭活疫苗(NMG株)获得新兽药注册证书
图解金河生物三季报：第三季度单季净利润同比增长92.07%
证券之星 · 10-30
图解金河生物三季报：第三季度单季净利润同比增长92.07%
金河生物(002688.SZ)发布前三季度业绩，归母净利润1.33亿元，同比下降4.29%
智通财经 · 10-29
金河生物(002688.SZ)发布前三季度业绩，归母净利润1.33亿元，同比下降4.29%
金河生物(002688)9月30日股东户数4.42万户，较上期减少0.67%
证券之星 · 10-29
金河生物(002688)9月30日股东户数4.42万户，较上期减少0.67%
股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第五次临时股东会的法律意见书》
证券之星 · 10-12
股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第五次临时股东会的法律意见书》
金河生物（002688）披露部分股票期权注销完成公告，10月09日股价上涨1.73%
证券之星 · 10-09
金河生物（002688）披露部分股票期权注销完成公告，10月09日股价上涨1.73%
金河生物（002688）披露2024年股票期权激励计划第二个行权期行权结果暨股份上市公告，9月30日股价上涨1.17%
证券之星 · 09-30
金河生物（002688）披露2024年股票期权激励计划第二个行权期行权结果暨股份上市公告，9月30日股价上涨1.17%
股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第四次临时股东会的法律意见书》
证券之星 · 09-28
股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第四次临时股东会的法律意见书》
股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第四次临时股东会的法律意见书》
证券之星 · 09-24
股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第四次临时股东会的法律意见书》
金河生物（002688）披露回购注销部分限制性股票及注销库存股减少注册资本公告，9月23日股价下跌1.71%
证券之星 · 09-23
金河生物（002688）披露回购注销部分限制性股票及注销库存股减少注册资本公告，9月23日股价下跌1.71%
金河生物（002688）50万股限售股将于9月21日解禁，占总股本0.06%
证券之星 · 09-21
金河生物（002688）50万股限售股将于9月21日解禁，占总股本0.06%
金河生物（002688）495.6万股限售股将于9月15日解禁，占总股本0.59%
证券之星 · 09-15
金河生物（002688）495.6万股限售股将于9月15日解禁，占总股本0.59%
股市必读：金河生物新发布《关于2023年限制性股票激励计划首次授予第三个解除限售期解除限售股份上市流通的提示性公告》
证券之星 · 09-14
股市必读：金河生物新发布《关于2023年限制性股票激励计划首次授予第三个解除限售期解除限售股份上市流通的提示性公告》
金河生物（002688）披露2023年限制性股票激励计划首次授予第三个解除限售期解除限售股份上市流通提示性公告，9月10日股价下跌1.82%
证券之星 · 09-10
金河生物（002688）披露2023年限制性股票激励计划首次授予第三个解除限售期解除限售股份上市流通提示性公告，9月10日股价下跌1.82%
股市必读：金河生物（002688）9月4日董秘有最新回复
证券之星 · 09-07
股市必读：金河生物（002688）9月4日董秘有最新回复
金河生物：后续公司将通过强化全面预算管控、完善绩效考核、严控非必要开支
证券之星 · 09-01
金河生物：后续公司将通过强化全面预算管控、完善绩效考核、严控非必要开支
股市必读：金河生物新发布《第七届董事会第八次会议决议公告》
证券之星 · 09-01
股市必读：金河生物新发布《第七届董事会第八次会议决议公告》
金河生物（002688）披露美国子公司对外投资建设项目议案，8月31日股价下跌1.15%
证券之星 · 08-31
金河生物（002688）披露美国子公司对外投资建设项目议案，8月31日股价下跌1.15%
加载更多
公司概况
公司名称：
金河生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2012-07-13
主营业务：
金河生物科技股份有限公司的主营业务是动物保健品业务、环保业务及农产品加工业务。公司的主要产品是兽用化药、兽用疫苗、药物饲料添加剂、玉米淀粉及联产品、环保服务。公司是兽用化药金霉素预混剂行业的龙头企业，全球最大的兽用化药金霉素预混剂生产企业。
发行价格：
18.00
{"stockData":{"symbol":"002688","market":"SZ","secType":"STK","nameCN":"金河生物","latestPrice":4.55,"timestamp":1794553398000,"preClose":4.57,"halted":0,"volume":6061375,"delay":0,"changeRate":-0.0044,"floatShares":749000000,"shares":836999999,"eps":0.0258,"marketStatus":"已收盘","change":-0.02,"latestTime":"11-13 15:00:00","open":4.57,"high":4.63,"low":4.53,"amount":27698800,"amplitude":0.0219,"askPrice":4.56,"askSize":1198,"bidPrice":4.55,"bidSize":69,"shortable":0,"etf":0,"ttmEps":0.0258,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794792600000},"marketStatusCode":5,"adr":0,"adjPreClose":4.57,"symbolType":"stock","openAndCloseTimeList":[[1794533400000,1794540600000],[1794546000000,1794553200000]],"highLimit":5.03,"lowLimit":4.11,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":837377701,"isCdr":false,"pbRate":1.47,"roa":"--","peRate":176.356589,"roe":"5.8%","epsLYR":0.0353,"committee":0.118289,"marketValue":3810000000,"turnoverRate":0.0081,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-11-16。","floatMarketCap":3408000000},"requestUrl":"/m/hq/s/002688/","defaultTab":"news","newsList":[{"id":"2682085584","title":"股市必读：金河生物新发布《关于子公司获得新兽药注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2682085584","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682085584?lang=zh_cn&edition=full","pubTime":"2026-11-12 03:56","pubTimestamp":1794426970,"startTime":"0","endTime":"0","summary":"截至2026年11月11日收盘，金河生物报收于4.62元，上涨0.22%，换手率0.57%，成交量4.27万手，成交额1972.79万元。该疫苗用于预防牛结节性皮肤病，免疫期为6个月，适用于2月龄以上牛。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200004417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682316466","title":"金河生物（002688）披露子公司获得新兽药注册证书公告，11月10日股价下跌0.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682316466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682316466?lang=zh_cn&edition=full","pubTime":"2026-11-10 22:29","pubTimestamp":1794320994,"startTime":"0","endTime":"0","summary":"截至2026年11月10日收盘，金河生物报收于4.61元，较前一交易日下跌0.43%，最新总市值为38.6亿元。近日，金河生物科技股份有限公司发布公告称，其子公司金河佑本生物制品有限公司联合金宇保灵生物药品有限公司、洛阳沃普森生物工程有限公司共同研发的牛结节性皮肤病灭活疫苗获农业农村部批准为一类新兽药，并取得新兽药注册证书。该疫苗用于预防牛结节性皮肤病，免疫期为6个月，适用于2月龄以上牛。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000047322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682364061","title":"金河生物(002688.SZ)：牛结节性皮肤病灭活疫苗(NMG株)获得新兽药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2682364061","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682364061?lang=zh_cn&edition=full","pubTime":"2026-11-10 16:07","pubTimestamp":1794298076,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金河生物(002688.SZ)发布公告，根据《兽药管理条例》和《兽药注册办法》规定，经农业农村部审查，批准公司子公司金河佑本生物制品有限公司(以下简称“金河佑本”)、金宇保灵生物药品有限公司、洛阳沃普森生物工程有限公司联合开发的牛结节性皮肤病灭活疫苗(NMG株)为新兽药，核发了《新兽药注册证书》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1521014.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4168","NMG","002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679383322","title":"图解金河生物三季报：第三季度单季净利润同比增长92.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679383322","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679383322?lang=zh_cn&edition=full","pubTime":"2026-10-30 02:24","pubTimestamp":1793298245,"startTime":"0","endTime":"0","summary":"证券之星消息，金河生物2026年三季报显示，前三季度公司主营收入20.94亿元，同比上升2.86%；归母净利润1.33亿元，同比下降4.29%；扣非净利润1.25亿元，同比上升0.39%；其中2026年第三季度，公司单季度主营收入6.47亿元，同比上升0.12%；单季度归母净利润220.8万元，同比上升92.07%；单季度扣非净利润-38.19万元，同比上升88.24%；负债率51.74%，投资收益1.14万元，财务费用7382.07万元，毛利率36.36%。财报数据概要请见下图:本文数据来源于金河生物2026年三季报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000005133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679313400","title":"金河生物(002688.SZ)发布前三季度业绩，归母净利润1.33亿元，同比下降4.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679313400","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679313400?lang=zh_cn&edition=full","pubTime":"2026-10-29 20:50","pubTimestamp":1793278227,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金河生物(002688.SZ)发布2026年第三季度报告，公司前三季度实现营业收入20.94亿元，同比增长2.86%;归属于上市公司股东的净利润1.33亿元，同比下降4.29%;归属于上市公司股东的扣除非经常性损益的净利润1.25亿元，同比增长0.39%;基本每股收益0.1713元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515469.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679403484","title":"金河生物(002688)9月30日股东户数4.42万户，较上期减少0.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679403484","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679403484?lang=zh_cn&edition=full","pubTime":"2026-10-29 19:07","pubTimestamp":1793272067,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金河生物披露，截至2026年9月30日公司股东户数为4.42万户，较6月30日减少300.0户，减幅为0.67%。在动物保健行业个股中，金河生物股东户数高于行业平均水平，截至9月30日，动物保健行业平均股东户数为1.87万户。从股价来看，2026年6月30日至2026年9月30日，金河生物区间涨幅为12.55%，在此期间股东户数减少300.0户，减幅为0.67%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900045878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674208846","title":"股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第五次临时股东会的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674208846","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674208846?lang=zh_cn&edition=full","pubTime":"2026-10-12 04:10","pubTimestamp":1791749422,"startTime":"0","endTime":"0","summary":"公司公告汇总关于金河生物科技股份有限公司2026年第五次临时股东会的法律意见书北京市华联律师事务所出具法律意见书，认为金河生物2026年第五次临时股东会的召集召开程序、出席人员资格、召集人资格、表决程序及表决结果均符合相关法律法规及公司章程规定，会议决议合法有效；会议审议通过《关于增加公司2026年度日常经营关联交易预计额度的议案》，关联股东已回避表决，中小投资者单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200001353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674391868","title":"金河生物（002688）披露部分股票期权注销完成公告，10月09日股价上涨1.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674391868","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674391868?lang=zh_cn&edition=full","pubTime":"2026-10-09 22:46","pubTimestamp":1791557176,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘，金河生物报收于5.3元，较前一交易日上涨1.73%，最新总市值为44.38亿元。近日，金河生物科技股份有限公司披露《关于部分股票期权注销完成的公告》。2026年10月8日，该注销事项已由中国证券登记结算有限责任公司深圳分公司审核确认完成。本次注销符合相关规定，程序合规，不影响公司股本结构及财务状况，不损害公司及股东利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900038752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671075270","title":"金河生物（002688）披露2024年股票期权激励计划第二个行权期行权结果暨股份上市公告，9月30日股价上涨1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671075270","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671075270?lang=zh_cn&edition=full","pubTime":"2026-09-30 17:43","pubTimestamp":1790761398,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘，金河生物报收于5.2元，较前一交易日上涨1.17%，最新总市值为43.54亿元。金河生物近日披露《关于2024年股票期权激励计划第二个行权期行权结果暨股份上市的公告》。本次行权新增股份数量为0股，行权股份上市日为2026年9月29日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000028512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670401443","title":"股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第四次临时股东会的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670401443","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670401443?lang=zh_cn&edition=full","pubTime":"2026-09-28 03:55","pubTimestamp":1790538912,"startTime":"0","endTime":"0","summary":"公司公告汇总：2026年第四次临时股东会审议通过回购注销限制性股票、注销回购专用账户库存股、变更注册资本及修订公司章程三项议案。公司公告汇总关于金河生物科技股份有限公司2026年第四次临时股东会的法律意见书北京市华联律师事务所就金河生物科技股份有限公司2026年第四次临时股东会的召集召开程序、出席人员资格、召集人资格、表决程序及表决结果等出具法律意见。上述事项完成后，公司总股本将由837,377,701股变更为836,082,701股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669337284","title":"股市必读：金河生物新发布《关于金河生物科技股份有限公司2026年第四次临时股东会的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669337284","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669337284?lang=zh_cn&edition=full","pubTime":"2026-09-24 02:38","pubTimestamp":1790188692,"startTime":"0","endTime":"0","summary":"公司公告汇总：金河生物于2026年9月23日召开第四次临时股东会，审议通过回购注销限制性股票、注销回购专用账户库存股、变更注册资本及修订公司章程三项议案。公司公告汇总关于金河生物科技股份有限公司2026年第四次临时股东会的法律意见书北京市华联律师事务所就金河生物科技股份有限公司2026年第四次临时股东会的召集召开程序、出席人员资格、召集人资格、表决程序及表决结果等出具法律意见。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400002581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669484165","title":"金河生物（002688）披露回购注销部分限制性股票及注销库存股减少注册资本公告，9月23日股价下跌1.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669484165","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669484165?lang=zh_cn&edition=full","pubTime":"2026-09-23 22:28","pubTimestamp":1790173697,"startTime":"0","endTime":"0","summary":"截至2026年9月23日收盘，金河生物报收于5.17元，较前一交易日下跌1.71%，最新总市值为43.29亿元。该股当日开盘5.27元，最高5.27元，最低5.16元，成交额达3657.91万元，换手率为0.94%。公告显示，因2名激励对象离职、22名激励对象业绩考核不达标，公司拟回购注销限制性股票1,170,000股；同时拟将回购专用证券账户内125,000股库存股注销以减少注册资本。上述事项完成后，公司总股本将由837,377,701股变更为836,082,701股。公司债权人自公告之日起45日内可要求清偿债务或提供担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300041208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669133349","title":"金河生物（002688）50万股限售股将于9月21日解禁，占总股本0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669133349","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669133349?lang=zh_cn&edition=full","pubTime":"2026-09-21 08:02","pubTimestamp":1789948936,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，金河生物于9月21日将有50.0万股限售股份解禁，为公司股权激励限售股份，占公司总股本0.06%。最近一年内，该股累计解禁495.6万股，占总股本的0.59%。本次解禁后，公司还有8616.61万股限售股份，占总股本10.29%。金河生物主营业务：专业从事动物保健品生产、销售、研发及服务,为客户提供一体化动物保健综合产品服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100000952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667694543","title":"金河生物（002688）495.6万股限售股将于9月15日解禁，占总股本0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667694543","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667694543?lang=zh_cn&edition=full","pubTime":"2026-09-15 08:14","pubTimestamp":1789431271,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，金河生物于9月15日将有495.6万股限售股份解禁，为公司股权激励限售股份，占公司总股本0.59%。本次解禁后，公司还有8538.06万股限售股份，占总股本10.2%。金河生物主营业务：专业从事动物保健品生产、销售、研发及服务,为客户提供一体化动物保健综合产品服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500005993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667638618","title":"股市必读：金河生物新发布《关于2023年限制性股票激励计划首次授予第三个解除限售期解除限售股份上市流通的提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667638618","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667638618?lang=zh_cn&edition=full","pubTime":"2026-09-14 03:23","pubTimestamp":1789327390,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，金河生物报收于5.24元，下跌2.78%，换手率1.78%，成交量13.33万手，成交额6988.03万元。公司公告汇总关于2023年限制性股票激励计划首次授予第三个解除限售期解除限售股份上市流通的提示性公告本次符合解除限售条件的激励对象为88名，可解除限售的限制性股票数量为4,956,000股，占公司总股本的0.5918%；限售起始日为2023年7月7日，限售期限36个月；上市流通日为2026年9月15日；公司层面及个人层面考核条件均已满足。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666591780","title":"金河生物（002688）披露2023年限制性股票激励计划首次授予第三个解除限售期解除限售股份上市流通提示性公告，9月10日股价下跌1.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666591780","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666591780?lang=zh_cn&edition=full","pubTime":"2026-09-10 22:30","pubTimestamp":1789050634,"startTime":"0","endTime":"0","summary":"近日，金河生物科技股份有限公司发布《关于2023年限制性股票激励计划首次授予第三个解除限售期解除限售股份上市流通的提示性公告》。公告显示，本次符合解除限售条件的激励对象为88名，可解除限售的限制性股票数量为4,956,000股，占公司总股本的0.5918%。限售起始日为2023年7月7日，限售期限36个月，上市流通日为2026年9月15日。公司层面及个人层面考核条件均已满足，相关股份将于解除限售后上市流通。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000042253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665627773","title":"股市必读：金河生物（002688）9月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2665627773","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665627773?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:17","pubTimestamp":1788715028,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，金河生物报收于5.28元，上涨1.73%，换手率2.07%，成交量15.46万手，成交额8174.02万元。董秘最新回复投资者： 请问截止至2026年9月1日股东人数是多少谢谢董秘： 您好，为保证信息披露的公平性，公司会在定期报告中对股东情况作出统一披露。当日关注点交易信息汇总：9月4日主力资金净流入294.29万元，占总成交额3.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664790836","title":"金河生物：后续公司将通过强化全面预算管控、完善绩效考核、严控非必要开支","url":"https://stock-news.laohu8.com/highlight/detail?id=2664790836","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664790836?lang=zh_cn&edition=full","pubTime":"2026-09-01 15:03","pubTimestamp":1788246194,"startTime":"0","endTime":"0","summary":"金河生物回复：您好，公司2026年半年度管理费用较上年同期增加19.23%，主要系随着公司业务的发展，产品细分种类增加，从事相关工作的管理人员随之增加，叠加社保基数上调等因素总体职工薪酬同比增加幅度较大；受下游市场低迷影响，部分疫苗产能未能释放，停工产生的相关费用计入管理费用所致。后续公司将通过强化全面预算管控、完善绩效考核、严控非必要开支，统筹提升子公司运营效率，分类管控费用，推动费用增长逐步与收入水平相匹配。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100021215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000279","title":"股市必读：金河生物新发布《第七届董事会第八次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000279","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664000279?lang=zh_cn&edition=full","pubTime":"2026-09-01 03:07","pubTimestamp":1788203231,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，金河生物报收于5.16元，下跌1.15%，换手率1.08%，成交量8.07万手，成交额4166.83万元。公司公告汇总：董事会审议通过美国子公司两项对外投资项目，合计预计总投资约3,192.46万美元，资金来源为子公司自有或自筹资金，无需提交股东大会审议。交易信息汇总资金流向8月31日主力资金净流入139.13万元，占总成交额3.34%；游资资金净流入345.42万元，占总成交额8.29%；散户资金净流出484.55万元，占总成交额11.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100002636.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663001193","title":"金河生物（002688）披露美国子公司对外投资建设项目议案，8月31日股价下跌1.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663001193","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663001193?lang=zh_cn&edition=full","pubTime":"2026-08-31 22:31","pubTimestamp":1788186704,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，金河生物报收于5.16元，较前一交易日下跌1.15%，最新总市值为43.21亿元。该股当日开盘5.21元，最高5.22元，最低5.13元，成交额达4166.83万元，换手率为1.08%。近日，金河生物科技股份有限公司披露第七届董事会第八次会议决议公告。会议以9票同意、0票反对、0票弃权审议通过了《关于美国子公司对外投资建设项目的议案》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100037586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794627344071,"stockEarnings":[{"period":"1week","weight":-0.0257},{"period":"1month","weight":-0.1008},{"period":"3month","weight":-0.125},{"period":"6month","weight":-0.2121},{"period":"1year","weight":-0.2728},{"period":"ytd","weight":-0.2214}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":-0.0353},{"period":"3month","weight":-0.0746},{"period":"6month","weight":-0.1212},{"period":"1year","weight":-0.0981},{"period":"ytd","weight":-0.0843}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金河生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"44166人(较上一季度减少0.67%)","perCapita":"16957股","listingDate":"2012-07-13","address":"内蒙古自治区呼和浩特市托克托县新坪路71号","registeredCapital":"83737万元","survey":" 金河生物科技股份有限公司的主营业务是动物保健品业务、环保业务及农产品加工业务。公司的主要产品是兽用化药、兽用疫苗、药物饲料添加剂、玉米淀粉及联产品、环保服务。公司是兽用化药金霉素预混剂行业的龙头企业，全球最大的兽用化药金霉素预混剂生产企业。","listedPrice":18},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金河生物(002688)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金河生物(002688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金河生物,002688,金河生物股票,金河生物股票老虎,金河生物股票老虎国际,金河生物行情,金河生物股票行情,金河生物股价,金河生物股市,金河生物股票价格,金河生物股票交易,金河生物股票购买,金河生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金河生物(002688)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金河生物(002688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}